Jens Juul Holst

Jens Juul Holst

Professor

ORCID: 0000-0001-6853-3805

Publication year:
All
1521 - 1530 out of 1,841Page size: 10
  1. 2001
  2. Published

    Incretin hormones--an update

    Holst, Jens Juul & Ørskov, Cathrine, 2001, In: Scandinavian Journal of Clinical & Laboratory Investigation. 234, p. 75-85 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Incretin hormones - an update

    Holst, Jens Juul & Orskov, C., 2001, In: Scand J Clin Lab Inv. 61 Suppl. 234, p. 75-85

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Reference intervals for plasma glucose, insulin, proinsulin, C-peptide and counterregulatory factors during a 72-hour fast in healthy human subjects

    Højlund, K., Eshøj, O., Christensen, M. W., Skjærbæk, C., Frystyk, J., Holst, Jens Juul, Koldkjær, O., Møller J., D. & Beck-Nielsen, H., 2001, In: American Journal of Physiology.. 280, p. E50-E58

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon

    Jeppesen, Palle Bekker, Hartmann, Bolette, Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, Steen Seier, Madsen, J. L., Holst, Jens Juul & Mortensen, P. B., Mar 2001, In: Gastroenterology. 120, 4, p. 806-815 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide

    Jeppesen, P. B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., Holst, Jens Juul & Mortensen, P. B., 2001, In: Today in Medicine. Gastroenterology. 120, p. 806-815

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: selection of NN2211 for clinical development

    Knudsen, L. B., Agerso, H., Bjenning, C. & Holst, Jens Juul, 2001, In: Drug Future. 26, p. 677-685

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats

    Ljungmann, K., Hartmann, B., Kissmeyer-Nielsen, P. & Holst, Jens Juul, 2001, In: Am J Physiol-Gastr L. 281, p. G779-G785

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

    Meier, J. J., Huking, K., Holst, Jens Juul, Deacon, Carolyn F., Schmiegel, W. H. & Nauck, M. A., 2001, In: Diabetes. 50, p. 2497-2504

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    GLP-1 inhibits gastric emptying of water but does not influence plasma vasopressin, sodium, or osmolality

    Naslund, E., Bogefors, J., Gryback, P. & Holst, Jens Juul, 2001, In: Scand J Gastroentero. 36, p. 156-162

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Glucagon-like peptide 2 stimulates small-intestine growth and maturation in the pig fetus and neonate

    Petersen, Y. M., Burrin, D. G., Schmidt, M., Elnif, J., Hartmann, B., Holst, Jens Juul & Sangild, Per Torp, 2001, Ikke angivet. Lindberg, J. E., Ogle & B. (eds.). CABI Publishing, p. 23-25 3 p.

    Research output: Chapter in Book/Report/Conference proceeding › Article in proceedings › Research

Previous 1...149 150 151 152 153 154 155 156 ...185 Next

ID: 4207